Guest View
User: Pass: | become a member


Staging Trades

Nothing pleases me more on the weekend than having an opportunity to chat with wily old investors that have “been there, done that and seen it all!” So, it was with great pleasure this weekend that I scheduled a chat with an old friend who has been around the real-estate investing block more times than he cares to remember. 
In the midst of our discussion he spoke of his children. One son in particular had a penchant for starting a venture involving organic fresh food. Given the increased sophistication among the general populous towards exercise and diet in recent years I thought this sounded like a winning concept if he could execute well. However, it came as a surprise to me that my friend strongly discouraged his son from launching his company. Instead, he encouraged him to become an investor.
The reason behind his advice emanated from one of the habits discussed in Stephen Covey’s “7 Habits of Highly Effective People”, which is to “Start with the End in Mind”. For most of us, career and learning take up most of our formative years while investing is shelved to a later stage. The danger, as he perceived it, for his son was that he would work a lifetime, save a nice sum of money and one day would seek to invest it but would have no idea where to begin.
Just think about all the hours demanded of the average employee. So much time and energy is invested to save money and yet, at retirement, many people who worked so hard for the capital they saved, often deploy it quickly to “investments” without much due diligence or consideration. The old investing rule of thumb is that if you spend more time researching the purchase of a car then you do purchasing a stock that is comparably priced, it’s time to stop trading and start learning! 
With that said if you know that you are going to be an investor, do all you can to learn as much about investing as possible as soon as possible. We are here to help in any way we reasonably can.
Digressions aside, let’s get to the concept of staging trades. Most novice investors follow the rash decision-making process I alluded to above. They find a trade, put all their capital on the position and then hope for the best! It’s just human nature and most of us have been there at some point or another. However, it’s not smart! 
Instead, consider deploying capital in stages. If you like a stock, consider buying in increments that start small and increase over time. For example, if I liked a $30 stock and decided I would deploy $15,000 to the position, I might start with simply a $3,000 purchase. As the stock would move lower to a support level and assuming I was still comfortable with the fundamentals I would commit more capital, another $3,000. The second tranche of capital buys more shares and lowers cost basis, while I still have cash on hand to purchase additional shares on further declines. 
The danger with this trading approach is that if the stock continues to decline and you run out of capital, you also run out of options; you are forced to remain with the losing position and hope for a reprieve via a stock rebound or cut and run. Options afford us the opportunity to assume much lower risk while also applying a staged approach. 
Let’s assume that market uncertainty is at a peak. This is usually evident when the market is dropping fast and volatility is high (which it is – just take a look at the VIX that recently shot up to 28). Instead of trying to enter a directional trade, I could apply a well-hedged trade. 
For example, General Electric is up almost two dollars since the start of the year, a gain of approximately 5% to just over $38 per share. Now, if I take a look at the dollar index, I can see that it dropped by over twice that percentage. So in real terms the dollars that General Electric was worth at the start of the year were worth more than the dollars it is worth now. Hence, even though the stock price has risen, the real return is negative. 
Now I might decide that the business itself is not worth less than it was almost a year ago and I actually believe the stock will go higher BUT I am not convinced and wish to hedge so I could enter the following trade:
Jan 09 Strike 30 Long Call Debit $10.05
Mar 08 Strike 40 Long Put Debit $3.45
The cost of the position is $13.50 while the risk is simply the cost of the trade minus the difference in strike prices while I hold both positions.
Risk = $13.45 – $10 = $3.45
If you do the math you can see that no matter where the stock ends up by Mar 08 expiration, you can never lose more than that $3.45.
This position is very well hedged as it stands. Now if the stock makes a big move to the upside the long call is so far in-the-money that it will make more money each time the stock rises a dollar than the long put would lose, hence the overall trade would profit. If the stock dropped substantially, let’s say to $30 then I might actually be in pretty good shape also!
If the stock dropped to $30, for example, the long call would likely retain a huge amount of its value because it is so far out in time and sits at-the-money where extrinsic value is highest while the long put would be far in-the-money and would be worth at least $10. All in all, the long call might lose $6-$7 while the long put would gain at least $6.55 (because long put would have at least $10 of intrinsic value). So even on a big decline the trade is probably close to breakeven and potentially slightly profitable.
However, this was a “staged trade”. That means I entered the first phase when uncertainty was at a peak. But what should I do when uncertainty has dissipated and I am more confident in the direction of the stock price? At that stage I can start to short options either side of the stock price. For example, I could sell put options against my existing long puts as the stock rises and when resistance is reached again I could enter short call options to further reduce my risk in the overall trade.
This type of trading is solid and relatively safe. In a market where volatility dominates, this is a great strategy to employ to minimize account value fluctuations and still offers the potential to produce handsome returns over time.
Have a fantastic week!
OptionSage
Do you know someone who would benefit from this information? We can send your friend a strictly confidential, one-time email telling them about this information. Your privacy and your friend's privacy is your business... no spam! Click here and tell a friend!



Comments


  1. Phil

    Very interesting what you say about spending as much time researching a car as a stock as I never consdidered my similar behavior in that regard. Before I buy a car I always rent it for a week (taking, effectively, an option) so I can really decide if it’s worth the investment. To me, there’s nothing in a brochure or a review that can substitute for actually taking a car and driving it around and putting the kids in it and going to the mall and through the city and sitting in traffic for a few days…

    In a very simple way, that is the same way I take up a long option position, I try it first, take it for a test drive, sell a call against a 1/4 positions and see how it goes. If it performs well, then perhaps I make a stronger commitment once I get the “feel” of it.

    Come to think of it, it’s also why I didn’t get married until I was 35! 8-)

  2. k1

    Sage- this post is fabulous. The notion of buying a put with less length because the market is uncertain (high VIX) is a great concept. And I’m intrigued by the ability to structure the combo so the put gains value fast enough in a drop to offset the loss of intrinsic in the long call. Cool strategy!

  3. k1

    Phil- LOL, I had the same thought.My motivation in all the digging I’ve been doing in the PSW archives is to learn as much about trading strategy as I can, while putting only a small amount of capital ‘at risk’ in my trades. Once I’m more confident in my ability to manage the strategy I’ll commit more cash to the pursuit.

  4. OptionSage

    LOLOLOLOL Phil!!!!!

    Thanks K1! – let’s just see if we make money now :-)

  5. Fan

    Not trying to spread panic but E-trade looks like it could have a very ugly run on the bank:

    E Trade Financial Corp (ETFC): Bankruptcy Risk Cannot Be Ruled
    2007-11-11 21:42 (New York)

    Citigroup – Equity Research 11 November 2007

    Investment Banking & Brokerage (GICS) | Brokers & Asset Managers (Citi)

    Company Focus – 12 pp.
    ********************************************************************************
    E Trade Financial Corp (ETFC) Sell/Speculative (3S)
    from Hold/Speculative

    Bankruptcy Risk Cannot Be Ruled Out-Downgrading To A Sell
    ********************************************************************************

    Prashant A Bhatia, CFA
    +1-212-816-1815
    prashant.bhatia@citi.com

    Christopher Moreno
    christopher.moreno@citi.com

    ——————————————————————————--

    * Downgrading to A Sell based on a higher probability of a run on the bank.
    The continued negative news flow about charges resulting from its mortgage &
    CDO exposure, an SEC inquiry, and continued deterioration in its financial
    condition, all increase the likelihood of significant client attrition.

    * 50% of deposits, representing $15b, are over $100,000 (the FDIC insurance
    threshold), and we view these deposits as having a higher risk of leaving.
    The $15b of deposits in 57,000 accounts represent roughly 25% of E*Trade’s
    funding, and deposit attrition could lead to forced selling of the assets
    that are supported by these deposits. There may be layers of protection for
    customers (multiple charters, other forms of insurance, etc.), but in our
    view, customers may withdraw assets first, and ask questions later.

    * We estimate that trying to liquidate E*Trade’s loan & ABS portfolio would
    result in over $5b of losses (more than wiping out tangible equity). Based on
    accounting convention, E*Trade is not required to mark-to-market certain
    loans and securities. However, in the event that it has to sell these assets
    as a result of losing its funding sources (e.g. deposits & repo lines),
    losses could be realized. Our haircuts to arrive at the $5b loss estimate
    include 10% on 1st lien loans, 20% on HELOCs, and 25% on its ABS portfolio.

    * Expect 4Q write-downs & provisions of $500m (~20% of tangible equity). We’re
    lowering our 07/08/09 earnings est to $0.31, $0.90, $0.90. Our TP of $7.50,
    includes a 15% probability of bankruptcy. Our lower estimates now forecast an
    $11b reduction in the B/S by the end of ’08 to enhance liquidity.

    ——————————————————————————--

    Price (09 Nov 07)……………US$8.59 Target price………………..US$7.50
    Expected share price return……-12.7% Expected dividend yield…………0.0%
    Expected total return…………-12.7% Market Cap………………..US$3,639M

    ——————————————————————————--
    Citi Investment Research is a division of Citigroup Global Markets Inc. (the
    “Firm”), which does and seeks to do business with companies covered in its
    research reports. As a result, investors should be aware that the Firm may have
    a conflict of interest that could affect the objectivity of this report.
    Investors should consider this report as only a single factor in making their
    investment decision. Non-US research analysts who have prepared this report are
    not registered/qualified as research analysts with the NYSE and/or NASD. Such
    research analysts may not be associated persons of the member organization and
    therefore may not be subject to the NYSE Rule 472 and NASD Rule 2711
    restrictions on communications with a subject company, public appearances and
    trading securities held by a research analyst account.
    Customers of the Firm in the United States can receive independent third-party
    research on the company or companies covered in this report, at no cost to them,
    where such research is available. Customers can access this independent research
    at http://www.smithbarney.com (for retail clients) or
    http://www.citigroupgeo.com (for institutional clients) or can call (866)
    836-9542 to request a copy of this research.
    ********************************************************************************

    ********************************************************************************

    E Trade Financial Corp

    Company description

    E*Trade provides brokerage and banking services including trading, investing,
    banking, and lending to retail, corporate, and institutional customers. As of
    September 30th, 2007, the company had $153 billion in trading and investment
    accounts (ex-unexercised options) and $29 billion in deposit accounts. The
    company has approximately 4.7 million active retail client accounts, of which
    about 80% are brokerage accounts. The company derived about 58% of its revenues
    from net interest in 2006 and commissions and principal transactions accounted
    for 30% of revenue. As of September 30, 2007, the company had $64 billion in
    assets ($40b mortgage-related), $4.1 billion in stockholders’ equity, and about
    4,100 employees.

    Investment strategy

    We rate the shares of ETFC Sell/Speculative (3S) based on our view that there
    is a real possibility of a run-on-the-bank scenario unfolding driven by negative
    news flow related to charges resulting from its mortgage & CDO exposure,
    regulatory inquiries, and continued deterioration in its financial condition.
    Additionally, over half of the firm’s deposits are comprised of balances over
    $100,000 (the FDIC insurance threshold) and we believe there is a risk these
    deposits will attrite. Furthermore, deposit attrition could force management to
    sell loans and securities at significant discounts and we estimate that if the
    firm’s portfolio was to be liquidated it would experience significant losses.
    Additionally, we believe the firm’s well capitalized status is at risk and a
    loss of this status could impact the firm’s access to additional liquidity.
    Furthermore, we note that 3 class-action lawsuits, 3 verified shareholder
    derivative complaints, and an SEC inquiry all were initiated during October ’07.
    Finally, the firm’s core business is producing limited organic growth and the
    firm has an unrealized loss on securities of in excess of $800m. We don’t
    believe the firm is a viable take-out candidate based on its rate and credit
    risk profile.

    Valuation

    We rate the shares of E*Trade 3/S (vs 2/S previously) with a target price of
    $7.50 (vs $13 previously). The primary driver of our lower rating and target
    price is a significant deterioration in E*Trade’s $60b securities and loan
    portfolio which will likely result in write-downs in excess of $500m.
    Furthermore, we are forecasting that in an effort to conserve liquidity,
    management will need to aggressively shrink the size of the balance sheet which
    will result in a meaningful decline in earnings power going forward. We use a
    discounted cash flow (DCF)-based model combined with our assumption of a 15%
    chance of bankruptcy to derive our target price. Our ten-year DCF forecast model
    assumes a cost of capital of 13% for the firm, a trailing 2-year beta of 1.9
    (source: Bloomberg), a risk-free rate of 5%, and an equity market premium of 4%
    (Source: 4yr Avg of CIR ERP). Our DCF model assumes a long-term growth rate of
    3% (vs 5% previously). Our lower growth rate is driven by management shrinking
    the balance sheet to conserve capital and our view that this franchise will
    continue to deliver little to no growth in the core discount brokerage business.
    About 50% of the firm’s total value is derived from our terminal value, and we
    estimate that a 50 bps change in our terminal growth rate assumption has about a
    $1 impact on the target price. Our DCF derives a target price of $9, we then
    layer on a 15% probability that the firm goes bankrupt to arrive at our target
    price of $7.50.

    Risks

    We rate the shares of ETFC Speculative Risk. Our risk rating is based on our
    view that the firm could face a potential run-on-the-bank scenario, has an
    outstanding SEC inquiry, has a $40b mortgage portfolio, and lacks meaningful
    organic growth. We believe the key risks related to E*Trade shares not reaching
    our target price are primarily related to a better than expected macro
    environment, improvement in consumer credit environment, higher retail activity
    levels, lower interest rates, and stickier than expected clients. Additionally,
    a take-out or capital infusion could potentially drive shares higher.

    Charles Schwab

    Investment Thesis

    We rate the shares of Charles Schwab Buy/Medium Risk (1M). Our view is that the
    Charles Schwab franchise has strong upside earnings leverage driven by the
    combination of continued organic growth, improved leverage of its cost
    infrastructure, and capitalizing on the growth opportunities in its core retail
    brokerage franchise, RIA business, and the corporate retirement servicing
    business. Based on our view of the strong upside earnings potential at Schwab, a
    greater proportion of fee-based revenue versus peers and best-in-class organic
    client asset gathering capability, we find the current valuation level
    compelling.

    Valuation

    We rate the shares of Charles Schwab Buy/Medium Risk (1M) with a target price
    of $27. We view our earnings estimates as conservative. We use a discounted cash
    flow (DCF) model as our valuation methodology to derive our target price. Our
    model uses net income as a proxy for cash flow. We assume a cost of capital of
    10% for the firm, a 5-year beta of 1.6 (source: Bloomberg), a risk free rate of
    5% and a market premium of 4% (source 4-yr average of CIR ERP). Our DCF model
    assumes an 11% average growth rate over the next 10 years gradually declining to
    our terminal growth rate of 4.5%. Using these estimates, we derive a target
    price of $27.

    Risk

    We rate SCHW shares Medium Risk because of its lower exposure to higher
    volatility trading related business and the lower degree of capital intensity in
    its business relative to peers, and a larger proportion of its revenue being
    derived from fee-based recurring revenue streams versus peers. We believe the
    key risks related to Schwab reaching our target price are primarily related to
    the macro environment, including the strength of the economy and the capital
    markets operating environment, especially retail investor activity levels and
    domestic financial asset values. Schwab is exposed to several industry specific
    risks including a prolonged equity market downturn, regulatory issues, changing
    market structure, low levels of retail client activity, and competition from
    other industry participants. Company specific risks include: execution risk
    related to Schwab’s strategic initiatives and daily operations, client asset
    attrition, potential negative impact from litigation, regulatory, or compliance
    issues. Additional risks include competitors cutting prices for products and
    services offered by Schwab, which could potentially increase client asset
    attrition. If the impact on the company from any of these factors proves to be
    greater than we anticipate, the stock will likely have difficulty achieving our
    target price.

    TD Ameritrade

    Investment Thesis

    We rate the shares of TD Ameritrade Buy/Medium Risk (1M). We believe that AMTD
    shares offer a good near-term risk/reward opportunity based on current relative
    valuation levels, leverage to a more active retail trading environment, and
    potential upside from synergies as a result of acquiring TDW USA and shifting to
    more of an asset gathering model. In our view, the shift to an asset gathering
    model will drive higher and more sustainable revenue and earnings growth and
    accelerate organic growth. Furthermore, we believe that AMTD’s current
    management team has a track record of creating shareholder value and of
    successfully integrating acquisitions; therefore, the firm looks well positioned
    to participate in an industry that is consolidating.

    Valuation

    We rate the shares of TD Ameritrade Buy/Medium Risk (1M) with a target price of
    $25. Our valuation methodology is a discounted cash flow valuation model that
    uses net income as a proxy for cash flow. We use a DCF as our valuation
    methodology because it incorporates our 10-year forecast for earnings growth
    rate of 6%, to reflect the asset gathering strategy. Our 10-year DCF forecast
    model assumes a cost of capital of 10.5% for the firm, a three-year beta of 1.8
    (source FactSet), a long-term growth rate of 5%, a risk-free rate of 4.5% and a
    current market premium of 4% (Source: 4yr Avg of CIR ERP). Approximately 55% of
    the firm’s total value is derived from the firm’s terminal value. We estimate
    that every 25bps change in the terminal growth rate has about a $0.50 impact on
    the stock price. We then layer on a 20% probability that consolidation takes
    place in the next 12 months. The 20% probability is based on a scenario analysis
    that would value ATMD at $30+ in a combination. Using these estimates we derive
    a target of $25.

    Risk

    We rate AMTD shares Medium Risk as a result of the firm’s leading market share
    of online retail trading activity and low-cost infrastructure that results in
    the highest levels of industry profitability. Furthermore, we believe that the
    AMTD business model requires little need for large amounts of excess capital
    because there is no proprietary risk-taking built into its model. Finally, we
    believe that Ameritrade has an opportunity to extract significant cost savings
    from its merger with TDW USA.
    Key risks we see related to AMTD reaching our target price are primarily
    related to the macro environment, including the strength of the economy and the
    equities markets operating environment (retail investor trading activity
    levels), and interest rate levels (i.e., flattening yield curve). AMTD is
    exposed to several industry-specific risks including a prolonged equity market
    downturn, intense price competition, low levels of retail client activity,
    falling interest rates, asset attrition, and competition from industry
    participants. Finally, we believe that merger integration risk can result in
    potentially high levels of client attrition. Company-specific risks include
    price-cuts by competitors, which could potentially increase client asset
    attrition and slow account growth, merger and acquisition risks, and the loss of
    key executives. Also, there is potential negative impact from litigation and/or
    compliance issues. If the negative impact on the firm from any of these factors
    proves to be greater than we anticipate, the stock would likely have difficulty
    achieving our target price.

    ********************************************************************************

    Appendix A-1

    Analyst Certification

    Each research analyst(s), strategist(s) or research associate(s) responsible
    for the preparation and content of this research report hereby certifies that,
    with respect to each issuer or security that the research analyst, strategist or
    research associate covers in this research report, all of the views expressed in
    this research report accurately reflect their personal views about those
    issuer(s) or securities. Each research analyst(s) strategist(s) or research
    associate(s) also certify that no part of their compensation was, is, or will
    be, directly or indirectly, related to the specific recommendation(s) or view(s)
    expressed by that research analyst, strategist or research associate in this
    research report.
    ——————————————————————————--

    IMPORTANT DISCLOSURES

    TD Ameritrade Holding Corp (AMTD)
    Ratings and Target Price History – Fundamental Research
    Analyst: Prashant Bhatia, CFA (covered since April 8 2005)
    ——————————————
    Target Closing
    Price Price
    Date Rating (USD) (USD)
    ——————————————
    8 Apr 05 *1M *13.25 10.54
    9 May 05 1M *15.50 13.42
    31 May 05 1M *16.00 14.86
    23 Jun 05 1M *17.00 18.25
    9 Sep 05 1M *17.50 21.10
    6 Dec 05 1M *23.00 24.65
    25 Oct 06 1M *21.00 16.11
    6 Jun 07 1M *25.00 20.71
    ——————————————
    *Indicates change.

    Chart current as of 3 November 2007

    E*Trade Financial Corp. (ETFC)
    Ratings and Target Price History – Fundamental Research
    Analyst: Prashant Bhatia, CFA (covered since May 18 2005)
    ——————————————
    Target Closing
    Price Price
    Date Rating (USD) (USD)
    ——————————————
    17 May 05 *2H *13.00 12.10
    21 Jul 05 2H *16.00 15.42
    8 Aug 05 2H *18.00 16.10
    15 Dec 05 2H *22.50 21.18
    6 Apr 06 2H *28.00 26.85
    19 Jan 07 2H 28.00 24.08
    18 Apr 07 2H *23.00 22.13
    12 Aug 07 *2S *19.00 16.09
    18 Sep 07 2S *15.00 14.00
    18 Oct 07 2S *13.00 11.47
    ——————————————
    *Indicates change.

    Chart current as of 3 November 2007

    The Charles Schwab Corporation (SCHW)
    Ratings and Target Price History – Fundamental Research
    Analyst: Prashant Bhatia, CFA (covered since November 23 2004)
    ——————————————
    Target Closing
    Price Price
    Date Rating (USD) (USD)
    ——————————————
    22 Nov 04 *1M *13.00 10.28
    14 Dec 04 1M *14.50 11.72
    12 Jul 05 1M *15.00 12.48
    18 Jul 05 1M *16.00 13.37
    15 Sep 05 1M *17.50 14.32
    15 Dec 05 1M *19.00 15.27
    3 Jan 06 1M 19.00 14.96
    28 Feb 06 1M *20.00 16.21
    10 Apr 06 1M *22.00 18.12
    16 Jul 07 1M *27.00 22.25
    ——————————————
    *Indicates change.

    Chart current as of 3 November 2007

    Customers of the Firm in the United States can receive independent thirdparty
    research on the company or companies covered in this report, at no cost to them,
    where such research is available. Customers can access this independent research
    at http://www.smithbarney.com (for retail clients) or
    http://www.citigroupgeo.com (for institutional clients) or can call (866)
    8369542 to request a copy of this research.
    ——————————————————————————--
    Citigroup Global Markets Inc. or its affiliates has received compensation for
    investment banking services provided within the past 12 months from E*Trade
    Financial Corp., TD Ameritrade Holding Corp and The Charles Schwab Corporation.
    ——————————————————————————--
    Citigroup Global Markets Inc. or an affiliate received compensation for
    products and services other than investment banking services from E*Trade
    Financial Corp., TD Ameritrade Holding Corp and The Charles Schwab Corporation
    in the past 12 months.
    ——————————————————————————--
    Citigroup Global Markets Inc. currently has, or had within the past 12 months,
    the following company(ies) as investment banking client(s): E*Trade Financial
    Corp., TD Ameritrade Holding Corp and The Charles Schwab Corporation.
    ——————————————————————————--
    Citigroup Global Markets Inc. currently has, or had within the past 12 months,
    the following company(ies) as clients, and the services provided were
    noninvestmentbanking, securitiesrelated: E*Trade Financial Corp., TD Ameritrade
    Holding Corp and The Charles Schwab Corporation.
    ——————————————————————————--
    Citigroup Global Markets Inc. currently has, or had within the past 12 months,
    the following company(ies) as clients, and the services provided were
    noninvestmentbanking, nonsecuritiesrelated: E*Trade Financial Corp., TD
    Ameritrade Holding Corp and The Charles Schwab Corporation.
    ——————————————————————————--
    Analysts’ compensation is determined based upon activities and services
    intended to benefit the investor clients of Citigroup Global Markets Inc. and
    its affiliates (“the
    ——————————————————————————--

    CITI INVESTMENT RESEARCH RATINGS DISTRIBUTION
    ——————————————————————————--
    Data current as of 30 September 2007 Buy Hold Sell
    ——————————————————————————--
    Citi Investment Research Global
    Fundamental Coverage (3358) 50% 38% 12%
    ——————————————————————————--
    % of companies in each rating category
    that are investment banking clients 53% 55% 42%
    ——————————————————————————--

    Fir”). Like all Firm employees, analysts receive compensation that is impacted
    by overall firm profitability, which includes revenues from, among other
    business units, the Private Client Division, Institutional Sales and Trading,
    and Investment Banking.
    ——————————————————————————--
    The Firm is a market maker in the publicly traded equity securities of E*Trade
    Financial Corp., TD Ameritrade Holding Corp and The Charles Schwab Corporation.
    ——————————————————————————--
    For important disclosures (including copies of historical disclosures)
    regarding the companies that are the subject of this Citi Investment Research
    product (“the Product”), please contact Citi Investment Research, 388 Greenwich
    Street, 29th Floor, New York, NY, 10013, Attention: Legal/Compliance. In
    addition, the same important disclosures, with the exception of the Valuation
    and Risk assessments and historical disclosures, are contained on the Firm’s
    disclosure website at http://www.citigroupgeo.com. Private Client Division clients
    should refer to http://www.smithbarney.com/research. Valuation and Risk assessments can
    be found in the text of the most recent research note/report regarding the
    subject company. Historical disclosures (for up to the past three years) will be
    provided upon request.
    ——————————————————————————--
    Guide to Fundamental Research Investment Ratings:Citi Investment Research’s
    stock recommendations include a risk rating and an investment rating.Risk
    ratings, which take into account both price volatility and fundamental criteria,
    are: Low (L), Medium (M), High (H), and Speculative (S).Investment ratings are a
    function of Citi Investment Research’s expectation of total return (forecast
    price appreciation and dividend yield within the next 12 months) and risk
    rating.For securities in developed markets (US, UK, Europe, Japan, and
    Australia/New Zealand), investment ratings are: Buy (1) (expected total return
    of 10% or more for LowRisk stocks, 15% or more for MediumRisk stocks, 20% or
    more for HighRisk stocks, and 35% or more for Speculative stocks); Hold (2)
    (0%10% for LowRisk stocks, 0%15% for MediumRisk stocks, 0%20% for HighRisk
    stocks, and 0%35% for Speculative stocks); and Sell (3) (negative total
    return).Investment ratings are determined by the ranges described above at the
    time of initiation of coverage, a change in investment and/or risk rating, or a
    change in target price (subject to limited management discretion). At other
    times, the expected total returns may fall outside of these ranges because of
    market price movements and/or other shortterm volatility or trading patterns.
    Such interim deviations from specified ranges will be permitted but will become
    subject to review by Research Management. Your decision to buy or sell a
    security should be based upon your personal investment objectives and should be
    made only after evaluating the stock’s expected performance and risk.
    ——————————————————————————--
    Guide to Corporate Bond Research Credit Opinions and Investment Ratings:
    ——————————————————————————--
    Citi Investment Research’s corporate bond research issuer publications include
    a fundamental credit opinion of Improving, Stable or Deteriorating and a
    complementary risk rating of Low (L), Medium (M), High (H) or Speculative (S)
    regarding the credit risk of the company featured in the report. The fundamental
    credit opinion reflects the CIR analyst’s opinion of the direction of credit
    fundamentals of the issuer without respect to securities market vagaries. The
    fundamental credit opinion is not geared to, but should be viewed in the context
    of debt ratings issued by major public debt ratings companies such as Moody’s
    Investors Service, Standard and Poor’s, and Fitch Ratings. CBR risk ratings are
    approximately equivalent to the following matrix: Low Risk Triple A to Low
    Double A; Low to Medium Risk High Single A through High Triple B; Medium to High
    Risk Mid Triple B through High Double B; High to Speculative Risk Mid Double B
    and Below. The risk rating element illustrates the analyst’s opinion of the
    relative likelihood of loss of principal when a fixed income security issued by
    a company is held to maturity, based upon both fundamental and market risk
    factors. Certain reports published by Citi Investment Research will also include
    investment ratings on specific issues of companies under coverage which have
    been assigned fundamental credit opinions and risk ratings. Investment ratings
    are a function of Citi Investment Research’s expectations for total return,
    relative return (to publicly available Citigroup bond indices performance), and
    risk rating. These investment ratings are: Buy/Overweight the bond is expected
    to outperform the relevant Citigroup bond market sector index (Broad Investment
    Grade, High Yield Market or Emerging Market), performances of which are updated
    monthly and can be viewed at http://sd.ny.ssmb.com/ using the “Indexes” tab;
    Hold/Neutral Weight the bond is expected to perform in line with the relevant
    Citigroup bond market sector index; or Sell/Underweight the bond is expected to
    underperform the relevant sector of the Citigroup indexes.
    ——————————————————————————--

    OTHER DISCLOSURES

    The subject company’s share price set out on the front page of this Product is
    quoted as at 09 November 2007 12:00 AM on the issuer’s primary market.
    ——————————————————————————--
    Citigroup Global Markets Inc. and/or its affiliates has a significant financial
    interest in relation to The Charles Schwab Corporation. (For an explanation of
    the determination of significant financial interest, please refer to the policy
    for managing conflicts of interest which can be found at http://www.citigroupgeo.com.)
    ——————————————————————————--
    For securities recommended in the Product in which the Firm is not a market
    maker, the Firm is a liquidity provider in the issuers’ financial instruments
    and may act as principal in connection with such transactions. The Firm is a
    regular issuer of traded financial instruments linked to securities that may
    have been recommended in the Product. The Firm regularly trades in the
    securities of the subject company(ies) discussed in the Product. The Firm may
    engage in securities transactions in a manner inconsistent with the Product and,
    with respect to securities covered by the Product, will buy or sell from
    customers on a principal basis.
    ——————————————————————————--
    Securities recommended, offered, or sold by the Firm: (i) are not insured by
    the Federal Deposit Insurance Corporation; (ii) are not deposits or other
    obligations of any insured depository institution (including Citibank); and
    (iii) are subject to investment risks, including the possible loss of the
    principal amount invested. Although information has been obtained from and is
    based upon sources that the Firm believes to be reliable, we do not guarantee
    its accuracy and it may be incomplete and condensed. Note, however, that the
    Firm has taken all reasonable steps to determine the accuracy and completeness
    of the disclosures made in the Important Disclosures section of the Product. The
    Firm’s research department has received assistance from the subject company(ies)
    referred to in this Product including, but not limited to, discussions with
    management of the subject company(ies). Firm policy prohibits research analysts
    from sending draft research to subject companies. However, it should be presumed
    that the author of the Product has had discussions with the subject company to
    ensure factual accuracy prior to publication. All opinions, projections and
    estimates constitute the judgment of the author as of the date of the Product
    and these, plus any other information contained in the Product, are subject to
    change without notice. Prices and availability of financial instruments also are
    subject to change without notice. Notwithstanding other departments within the
    Firm advising the companies discussed in this Product, information obtained in
    such role is not used in the preparation of the Product. Although Citi
    Investment Research does not set a predetermined frequency for publication, if
    the Product is a fundamental research report, it is the intention of Citi
    Investment Research to provide research coverage of the/those issuer(s)
    mentioned therein, including in response to news affecting this issuer, subject
    to applicable quiet periods and capacity constraints. The Product is for
    informational purposes only and is not intended as an offer or solicitation for
    the purchase or sale of a security. Any decision to purchase securities
    mentioned in the Product must take into account existing public information on
    such security or any registered prospectus.
    ——————————————————————————--
    Investing in nonU.S. securities, including ADRs, may entail certain risks. The
    securities of nonU.S. issuers may not be registered with, nor be subject to the
    reporting requirements of the U.S. Securities and Exchange Commission. There may
    be limited information available on foreign securities. Foreign companies are
    generally not subject to uniform audit and reporting standards, practices and
    requirements comparable to those in the U.S. Securities of some foreign
    companies may be less liquid and their prices more volatile than securities of
    comparable U.S. companies. In addition, exchange rate movements may have an
    adverse effect on the value of an investment in a foreign stock and its
    corresponding dividend payment for U.S. investors. Net dividends to ADR
    investors are estimated, using withholding tax rates conventions, deemed
    accurate, but investors are urged to consult their tax advisor for exact
    dividend computations. Investors who have received the Product from the Firm may
    be prohibited in certain states or other jurisdictions from purchasing
    securities mentioned in the Product from the Firm. Please ask your Financial
    Consultant for additional details. Citigroup Global Markets Inc. takes
    responsibility for the Product in the United States. Any orders by US investors
    resulting from the information contained in the Product may be placed only
    through Citigroup Global Markets Inc.
    ——————————————————————————--
    The Citigroup legal entity that takes responsibility for the production of the
    Product is the legal entity which the first named author is employed by. The
    Product is made available in Australia to wholesale clients through Citigroup
    Global Markets Australia Pty Ltd. (ABN 64 003 114 832 and AFSL No. 240992) and
    to retail clients through Citi Smith Barney Pty Ltd. (ABN 19 009 145 555 and
    AFSL No. 240813), Participants of the ASX Group and regulated by the Australian
    Securities & Investments Commission. Citigroup Centre, 2 Park Street, Sydney,
    NSW 2000. The Product is made available in Australia to Private Banking
    wholesale clients through Citigroup Pty Limited (ABN 88 004 325 080 and AFSL
    238098). Citigroup Pty Limited provides all financial product advice to
    Australian Private Banking wholesale clients through bankers and relationship
    managers. If there is any doubt about the suitability of investments held in
    Citigroup Private Bank accounts, investors should contact the Citigroup Private
    Bank in Australia. Citigroup companies may compensate affiliates and their
    representatives for providing products and services to clients. The Product is
    made available in Brazil by Citigroup Global Markets Brasil CCTVM SA, which is
    regulated by CVM Comissao de Valores Mobili?rios, BACEN Brazilian Central Bank,
    APIMEC Associa?ao Associa?ao dos Analistas e Profissionais de Investimento do
    Mercado de Capitais and ANBID Associa?ao Nacional dos Bancos de Investimento.
    Av. Paulista, 1111 11? andar CEP. 01311920 Sao Paulo SP. If the Product is being
    made available in certain provinces of Canada by Citigroup Global Markets
    (Canada) Inc. (“CGM Canada”), CGM Canada has approved the Product. Citigroup
    Place, 123 Front Street West, Suite 1100, Toronto, Ontario M5J 2M3. The Product
    may not be distributed to private clients in Germany. The Product is distributed
    in Germany by Citigroup Global Markets Deutschland AG & Co. KGaA, which is
    regulated by Bundesanstalt fuer Finanzdienstleistungsaufsicht (BaFin). Frankfurt
    am Main, Reuterweg 16, 60323 Frankfurt am Main. If the Product is made available
    in Hong Kong by, or on behalf of, Citigroup Global Markets Asia Ltd., it is
    attributable to Citigroup Global Markets Asia Ltd., Citibank Tower, Citibank
    Plaza, 3 Garden Road, Hong Kong. Citigroup Global Markets Asia Ltd. is regulated
    by Hong Kong Securities and Futures Commission. If the Product is made available
    in Hong Kong by The Citigroup Private Bank to its clients, it is attributable to
    Citibank N.A., Citibank Tower, Citibank Plaza, 3 Garden Road, Hong Kong. The
    Citigroup Private Bank and Citibank N.A. is regulated by the Hong Kong Monetary
    Authority. The Product is made available in India by Citigroup Global Markets
    India Private Limited, which is regulated by Securities and Exchange Board of
    India. Bakhtawar, Nariman Point, Mumbai 400021. The Product is made available in
    Indonesia through PT Citigroup Securities Indonesia. 5/F, Citibank Tower,
    Bapindo Plaza, Jl. Jend. Sudirman Kav. 5455, Jakarta 12190. Neither this Product
    nor any copy hereof may be distributed in Indonesia or to any Indonesian
    citizens wherever they are domiciled or to Indonesian residents except in
    compliance with applicable capital market laws and regulations. This Product is
    not an offer of securities in Indonesia. The securities referred to in this
    Product have not been registered with the Capital Market and Financial
    Institutions Supervisory Agency (BAPEPAMLK) pursuant to relevant capital market
    laws and regulations, and may not be offered or sold within the territory of the
    Republic of Indonesia or to Indonesian citizens through a public offering or in
    circumstances which constitute an offer within the meaning of the Indonesian
    capital market laws and regulations. If the Product was prepared by Citi
    Investment Research and distributed in Japan by Nikko Citigroup Limited (“NCL”),
    it is being so distributed under license. If the Product was prepared by NCL and
    distributed by Nikko Cordial Securities Inc. or Citigroup Global Markets Inc. it
    is being so distributed under license. NCL is regulated by Financial Services
    Agency, Securities and Exchange Surveillance Commission, Japan Securities
    Dealers Association, Tokyo Stock Exchange and Osaka Securities Exchange.
    ShinMarunouchi Building, 151 Marunouchi, Chiyodaku, Tokyo 1006520 Japan. In the
    event that an error is found in an NCL research report, a revised version will
    be posted on Citi Investment Research’s Global Equities Online (GEO) website. If
    you have questions regarding GEO, please call (81 3) 62703019 for help. The
    Product is made available in Korea by Citigroup Global Markets Korea Securities
    Ltd., which is regulated by Financial Supervisory Commission and the Financial
    Supervisory Service. Hungkuk Life Insurance Building, 226 Shinmunno 1GA,
    JongnoGu, Seoul, 110061. The Product is made available in Malaysia by Citigroup
    Global Markets Malaysia Sdn Bhd, which is regulated by Malaysia Securities
    Commission. Menara Citibank, 165 Jalan Ampang, Kuala Lumpur, 50450. The Product
    is made available in Mexico by Acciones y Valores Banamex, S.A. De C. V., Casa
    de Bolsa, which is regulated by Comision Nacional Bancaria y de Valores. Reforma
    398, Col. Juarez, 06600 Mexico, D.F. In New Zealand the Product is made
    available through Citigroup Global Markets New Zealand Ltd., a Participant of
    the New Zealand Exchange Limited and regulated by the New Zealand Securities
    Commission. Level 19, Mobile on the Park, 157 lambton Quay, Wellington. The
    Product is made available in Poland by Dom Maklerski Banku Handlowego SA an
    indirect subsidiary of Citigroup Inc., which is regulated by Komisja Papierow
    Wartosciowych i Gield. Bank Handlowy w Warszawie S.A. ul. Senatorska 16, 00923
    Warszawa. The Product is made available in the Russian Federation through ZAO
    Citibank, which is licensed to carry out banking activities in the Russian
    Federation in accordance with the general banking license issued by the Central
    Bank of the Russian Federation and brokerage activities in accordance with the
    license issued by the Federal Service for Financial Markets. Neither the Product
    nor any information contained in the Product shall be considered as advertising
    the securities mentioned in this report within the territory of the Russian
    Federation or outside the Russian Federation. The Product does not constitute an
    appraisal within the meaning of the Federal Law of the Russian Federation of 29
    July 1998 No. 135FZ (as amended) On Appraisal Activities in the Russian
    Federation. 810 Gasheka Street, 125047 Moscow. The Product is made available in
    Singapore through Citigroup Global Markets Singapore Pte. Ltd., a Capital
    Markets Services Licence holder, and regulated by Monetary Authority of
    Singapore. 1 Temasek Avenue, #3902 Millenia Tower, Singapore 039192. The Product
    is made available by The Citigroup Private Bank in Singapore through Citibank,
    N.A., Singapore branch, a licensed bank in Singapore that is regulated by
    Monetary Authority of Singapore. Citigroup Global Markets (Pty) Ltd. is
    incorporated in the Republic of South Africa (company registration number
    2000/025866/07) and its registered office is at 145 West Street, Sandton, 2196,
    Saxonwold. Citigroup Global Markets (Pty) Ltd. is regulated by JSE Securities
    Exchange South Africa, South African Reserve Bank and the Financial Services
    Board. The investments and services contained herein are not available to
    private customers in South Africa. The Product is made available in Taiwan
    through Citigroup Global Markets Inc. (Taipei Branch), which is regulated by
    Securities & Futures Bureau. No portion of the report may be reproduced or
    quoted in Taiwan by the press or any other person. No. 8 Manhattan Building,
    Hsin Yi Road, Section 5, Taipei 100, Taiwan. The Product is made available in
    Thailand through Citicorp Securities (Thailand) Ltd., which is regulated by the
    Securities and Exchange Commission of Thailand. 18/F, 22/F and 29/F, 82 North
    Sathorn Road, Silom, Bangrak, Bangkok 10500, Thailand. The Product is made
    available in United Kingdom by Citigroup Global Markets Limited, which is
    authorised and regulated by Financial Services Authority. This material may
    relate to investments or services of a person outside of the UK or to other
    matters which are not regulated by the FSA and further details as to where this
    may be the case are available upon request in respect of this material.
    Citigroup Centre, Canada Square, Canary Wharf, London, E14 5LB. The Product is
    made available in United States by Citigroup Global Markets Inc, which is
    regulated by NASD, NYSE and the US Securities and Exchange Commission. 388
    Greenwich Street, New York, NY 10013. Unless specified to the contrary, within
    EU Member States, the Product is made available by Citigroup Global Markets
    Limited, which is regulated by Financial Services Authority. Many European
    regulators require that a firm must establish, implement and make available a
    policy for managing conflicts of interest arising as a result of publication or
    distribution of investment research. The policy applicable to Citi Investment
    Research’s Products can be found at http://www.citigroupgeo.com. Compensation of equity
    research analysts is determined by equity research management and Citigroup’s
    senior management and is not linked to specific transactions or recommendations.
    The Product may have been distributed simultaneously, in multiple formats, to
    the Firm’s worldwide institutional and retail customers. The Product is not to
    be construed as providing investment services in any jurisdiction where the
    provision of such services would not be permitted. Subject to the nature and
    contents of the Product, the investments described therein are subject to
    fluctuations in price and/or value and investors may get back less than
    originally invested. Certain highvolatility investments can be subject to sudden
    and large falls in value that could equal or exceed the amount invested. Certain
    investments contained in the Product may have tax implications for private
    customers whereby levels and basis of taxation may be subject to change. If in
    doubt, investors should seek advice from a tax adviser. The Product does not
    purport to identify the nature of the specific market or other risks associated
    with a particular transaction. Advice in the Product is general and should not
    be construed as personal advice given it has been prepared without taking
    account of the objectives, financial situation or needs of any particular
    investor. Accordingly, investors should, before acting on the advice, consider
    the appropriateness of the advice, having regard to their objectives, financial
    situation and needs. Prior to acquiring any financial product, it is the
    client’s responsibility to obtain the relevant offer document for the product
    and consider it before making a decision as to whether to purchase the product.
    ——————————————————————————--
    This Product is not intended for distribution in Poland. Any receipt or review
    of the Product in Poland is not authorized by the Firm.
    ——————————————————————————--
    (c) 2007 Citigroup Global Markets Inc. ((c) Nikko Citigroup Limited, if this
    Product was prepared by it). Citi Investment Research is a division and service
    mark of Citigroup Global Markets Inc. and its affiliates and is used and
    registered throughout the world. Citigroup and the Umbrella Device are
    trademarks and service marks of Citigroup or its affiliates and are used and
    registered throughout the world. Nikko is a registered trademark of Nikko
    Cordial Corporation. All rights reserved. Any unauthorized use, duplication,
    redistribution or disclosure is prohibited by law and will result in
    prosecution. The information contained in the Product is intended solely for the
    recipient and may not be further distributed by the recipient. The Firm accepts
    no liability whatsoever for the actions of third parties. The Product may
    provide the addresses of, or contain hyperlinks to, websites. Except to the
    extent to which the Product refers to website material of the Firm, the Firm has
    not reviewed the linked site. Equally, except to the extent to which the Product
    refers to website material of the Firm, the Firm takes no responsibility for,
    and makes no representations or warranties whatsoever as to, the data and
    information contained therein. Such address or hyperlink (including addresses or
    hyperlinks to website material of the Firm) is provided solely for your
    convenience and information and the content of the linked site does not in
    anyway form part of this document. Accessing such website or following such link
    through the Product or the website of the Firm shall be at your own risk and the
    Firm shall have no liability arising out of, or in connection with, any such
    referenced website.
    ——————————————————————————--
    ADDITIONAL INFORMATION IS AVAILABLE UPON REQUEST
    ——————————————————————————--

    Provider ID: NAM11171
    -0- Nov/12/2007 2:42 GMT
    

  6. Phil

    Fan – That is some scary stuff! Don’t forget C competes with ETFC for those deposits so it is no surprise they would raise the safety issue as they angle to capture some of those $15Bn in deposits. I think the concerns are valid but, as it says right in the report: “investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this report.”

    If ETrade, or any of them go, we can short that group (small brokers) with abandon. Anyone with substantial amounts of cash in a brokerage account needs to have a conversation with their broker about what guarantees there are for their deposits and spreading your cash out is always a good idea.

    The Citi analysts, as usual, display their idiocy by calling SCHW a buy while rating ETFC a sell as there is nothing that will happen to ETFC that won’t happen to SCHW 30 days later if their premise is true. The same goes for AMTD.

  7. MrN

    Phil – Is there a good play on BA on this dip or still stay away? I don’t have any postion there currently.

    Reuters
    Dubai deals near $80 billion as Airbus and Boeing soar
    Monday November 12, 7:56 am ET
    By Jason Neely, European Aerospace & Airlines Correspondent

    DUBAI (Reuters) – Airbus (Paris:EAD.PA – News) and Boeing Co (NYSE:BA – News) ensured 2007 smashes all records for plane sales as deals announced at the Dubai air show neared $80 billion on Monday, powered by demand from Gulf Arab states.

    Airbus moved ahead of Boeing in their annual battle for orders, with both scoring key wins at Dubai, including orders for the Boeing 787 Dreamliner and the Airbus A350 XWB.

Dashboard

 Sector Performances (Today)

 Thermal Imaging

Utilities-0.54 %
 
Aerospace-0.61 %
 
Retail-Wholesale-0.62 %
 
Finance-0.79 %
 
Consumer Staples-1.09 %
 
Medical-1.09 %
 
Consumer Discretionary-1.14 %
 
Business Services-1.14 %
 
Computer and Technology-1.15 %
 
Transportation-1.35 %
 
Multi-Sector Conglomerate-1.40 %
 
Industrial Products-1.60 %
 
Oils-Energy-1.62 %
 
Auto-Tires-Trucks-1.64 %
 
Construction-1.74 %
 
Basic Materials-1.90 %